GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (LTS:0RBP) » Definitions » Ending Cash Position

Kiadis Pharma NV (LTS:0RBP) Ending Cash Position : €13.66 Mil (As of Dec. 2020)


View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Ending Cash Position?

Kiadis Pharma NV's Ending Cash Position for the quarter that ended in Dec. 2020 was €13.66 Mil.

Kiadis Pharma NV's quarterly Ending Cash Position declined from Dec. 2019 (€29.46 Mil) to Jun. 2020 (€19.81 Mil) and declined from Jun. 2020 (€19.81 Mil) to Dec. 2020 (€13.66 Mil).

Kiadis Pharma NV's annual Ending Cash Position declined from Dec. 2018 (€60.31 Mil) to Dec. 2019 (€29.46 Mil) and declined from Dec. 2019 (€29.46 Mil) to Dec. 2020 (€13.66 Mil).

Kiadis Pharma NV Ending Cash Position Historical Data

The historical data trend for Kiadis Pharma NV's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Ending Cash Position Chart

Kiadis Pharma NV Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 14.56 29.91 60.31 29.46 13.66

Kiadis Pharma NV Semi-Annual Data
Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.31 62.67 29.46 19.81 13.66

Kiadis Pharma NV Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kiadis Pharma NV's Ending Cash Position for the fiscal year that ended in Dec. 2020 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=29.459+-15.801
=13.66

Kiadis Pharma NV's Ending Cash Position for the quarter that ended in Dec. 2020 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=19.809+-6.151
=13.66

Kiadis Pharma NV Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (LTS:0RBP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (LTS:0RBP) » Definitions » Ending Cash Position
Comparable Companies
XAMS:VVY OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY HKSE:02269 OCSE:GMAB HKSE:01177 BMRN SZSE:300122 XBRU:UCB ALNY XAMS:GLPG HKSE:06160
Traded in Other Exchanges
N/A
Address
Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP
Website
https://www.kiadis.com
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (LTS:0RBP) Headlines

No Headlines